Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Ariel Graff-Guerrero, MD, PhD
JCP
Original Research
Anosognosia in MCI and AD
October 10, 2017
Although anosognosia—or impaired illness awareness—is common in Alzheimer's disease, it occurs less frequently in mild cognitive impairment. Read this article to learn if anosognosia in patients with mild cognitive...
Philip Gerretsen
,
Jun Ku Chung
,
Parita Shah
, et al
JCP
Original Research
Insight Into Schizophrenia in Earlier and Later Life
April 26, 2017
Over half of patients with schizophrenia experience impaired insight into their illness, which often contributes to negative outcomes. Here, increase your own insight into predicting which of your patients...
Philip Gerretsen
,
Aristotle N. Voineskos
,
Ariel Graff-Guerrero
, et al
JCP
Article
Hyperprolactinemia in Older Patients With Schizophrenia
December 28, 2016
Since older patients are known to be hypersensitive to antipsychotics, are they vulnerable to developing hyperprolactinemia with these drugs? This post hoc study looked at whether the dopamine D2/3...
Yusuke Iwata
,
Shinichiro Nakajima
,
Fernando Caravaggio
, et al
JCP
Original Research
Switching From 2 Antipsychotics to 1 Antipsychotic in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
January 27, 2016
Carol Borlido
,
Gary Remington
,
Ariel Graff-Guerrero
, et al
